Watch this space for timely and relevant events and webinars related to emerging issues in prostate cancer prevention, screening, and control.
Webinar: 2026 ACS Prostate Cancer Screening Guideline
Join us on November 20 for a discussion on the recently published 2026 American Cancer Society Guideline for the Early Detection of Prostate Cancer, with insights from the lead authors. Learn how the guideline has changed from the previous 2010 version, the evidence underlying these changes, and how it should inform clinical practice and patient counseling around prostate cancer screening.
Introducing Our Strategic Roadmap 2026-2029
Over the past year, the NPCRT has reaffirmed our commitment to our three strategic priorities and further developed a series of implementation strategies targeted at achieving key outcomes within each of the Priority areas. These elements are integrated into a Strategic Roadmap and will shape the work and priorities of the ACS NPCRT over the next three years (2026-2029).
American Cancer Society National Prostate Cancer Roundtable
Over the last three decades, cancer diagnosis and death rates in the U.S. have mostly been declining. Ten years ago, prostate cancer took on a new and troubling trend. With more cases of prostate cancer being found each year, the time has come to act. The American Cancer Society National Prostate Cancer Roundtable (ACS NPCRT) was established in 2024. The ACS NPCRT is a national coalition of member organizations united to advance national priorities in prostate cancer by promoting evidence-based strategies and catalyzing policy and patient care solutions. The American Cancer Society provides organizational leadership and expert staff support to the ACS NPCRT.
Our Mission
Our mission is to improve prostate cancer outcomes and survivorship through increasing awareness and equitable access to prevention, screening, and treatment. Ultimately, the ACS NPCRT envisions a world in which we work together to eliminate death and suffering from prostate cancer, for all.
New Resource!
ACS NPCRT Risk Assessment and Screening Toolkit for Primary Care Clinicians
By the Numbers
Knowledge is power. Learn more about prostate cancer, and how you can protect yourself and your family through early detection.
1 in 8
American men will face a prostate cancer diagnosis in their lifetime
333,830
New cases of prostate cancer will be diagnosed in the US in 2026.
3%
Increased incidence of prostate cancer diagnosis every year since 2014
>99%
5-year survival rate when prostate cancer is diagnosed at an early stage
Webinars and Events
Developing a Roadmap to Better Care
Let’s stem the tide.
The ACS NPCRT follows the Collective Impact model. Together, our members engage in collective action and consensus-building strategies to identify key areas in which intervention could improve the patient experience and lead to fewer deaths from prostate cancer. If you or your organization would like to consider joining our team, let us know by clicking the link below.
Our Sponsors
Other ACS Led Roundtables
The American Cancer Society serves at the backbone to seven mission-critical national roundtables. Click on the logos below to explore more about each roundtable.
